Case-control studies of cancer screening: theory and practice

Journal of the National Cancer Institute
K A CroninP C Prorok

Abstract

This review summarizes methodologic theories for the design of cancer screening case-control studies and examines the methods applied in studies published in English from 1980 through 1996. In addition to summarizing state-of-the-art methodologic approaches, we identify areas where obvious gaps exist between theory and practice, and we recommend potential areas where theory and methodology may need further development. In particular, we focus on three major areas: 1) the selection of case and control subjects, 2) the definition of exposure (i.e., exposure to the screening test), and 3) bias. Each area is considered carefully by summarizing current theory, reviewing cancer screening applications, and linking recommended methodologic approaches to those used in practice to identify areas where inconsistencies exist. In general, we found methodologic theory and practice in this field of research to be consistent. However, discrepancies were identified in the area of exposure definition, including the use of screening frequency and the use of a detectable, curable preclinical phase for case subjects as the exposure measures. Even when recommended methods were followed, a number of difficulties arose in practice. Specific concerns i...Continue Reading

References

Oct 21, 1992·Journal of the National Cancer Institute·P A NewcombP M Marcus
Aug 1, 1992·Journal of Epidemiology and Community Health·H J ColletteN E Day
Apr 1, 1992·American Journal of Epidemiology·N S WeissN G Stevens
Jan 26, 1991·Lancet·B GullbergJ Ranstam
Jan 21, 1992·International Journal of Cancer. Journal International Du Cancer·T SobueT Naruke
Mar 15, 1992·The New England Journal of Medicine·J V SelbyN S Weiss
Jan 1, 1991·Journal of Clinical Epidemiology·R J ConnorD L Weed
Jan 1, 1991·Public Health·G Knox
May 15, 1991·American Journal of Epidemiology·D R Friedman, N Dubin
Mar 1, 1991·International Journal of Epidemiology·S M Moss
Jul 1, 1990·Environmental Health Perspectives·T SobueT Naruke
Sep 1, 1989·Journal of Epidemiology and Community Health·D PalliE Paci
Oct 15, 1986·International Journal of Cancer. Journal International Du Cancer·D PalliG Maltoni
Dec 1, 1988·Japanese Journal of Cancer Research : Gann·T SobueI Fujimoto
Aug 15, 1987·International Journal of Cancer. Journal International Du Cancer·K Ebeling, P Nischan
Jan 1, 1987·Journal of Chronic Diseases·N DubinB S Pasternack
Jan 1, 1986·Journal of Chronic Diseases·A J SascoS D Walter
Dec 15, 1986·International Journal of Cancer. Journal International Du Cancer·A OshimaI Fujimoto
Mar 1, 1985·Irish Journal of Medical Science·P D Morrison
Jan 1, 1982·American Journal of Epidemiology·A S Morrison
Jan 1, 1995·Journal of Medical Screening·D LazovichE H Wagner
Jan 3, 1995·International Journal of Cancer. Journal International Du Cancer·A FukaoA Takano
Feb 1, 1995·Journal of Clinical Epidemiology·T M Gill, R I Horwitz
Jun 15, 1994·Journal of the National Cancer Institute·J A van DijckM Mravunac
Jun 1, 1994·British Journal of Cancer·P PisaniJ Vivas
Nov 1, 1993·Japanese Journal of Cancer Research : Gann·N HiwatashiT Toyota
Jan 15, 1996·American Journal of Epidemiology·R S HosekA J Sasco
Sep 1, 1952·American Journal of Public Health and the Nation's Health·L BRESLOW

❮ Previous
Next ❯

Citations

Oct 22, 2003·Lancet·John H Scholefield, Sue Moss
Nov 21, 2001·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·K NishiiM Harada
Jun 27, 2003·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Motoyasu SagawaShigefumi Fujimura
Jun 27, 2003·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Pamela M Marcus
Oct 21, 1999·Journal of Clinical Epidemiology·T R Church
Oct 26, 1999·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·L BertarioF Berrino
Oct 7, 2010·Annals of Oncology : Official Journal of the European Society for Medical Oncology·E PaapM J M Broeders
Apr 17, 2003·Journal of the National Cancer Institute·Jack S Mandel
Apr 17, 2003·Journal of the National Cancer Institute·Polly A NewcombJohn D Potter
Jan 12, 2001·Journal of Epidemiology and Community Health·D L Weed
Sep 22, 2012·BMC Medicine·Donella Puliti, Marco Zappa
Dec 14, 2012·BMC Medicine·Philippe Autier, Mathieu Boniol
Jun 1, 2010·Cancer Causes & Control : CCC·Ellen PaapMireille J M Broeders
Aug 31, 2013·Annals of Epidemiology·Rick J JansenTimothy R Church
Aug 21, 2013·American Journal of Preventive Medicine·Lauren P Wallner, Steven J Jacobsen
Dec 11, 2008·The Journal of Sexual Medicine·Ida J KorfageMarie-Louise Essink-Bot
Sep 29, 2011·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Philippe Autier
Dec 8, 2010·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Lonneke V van de Poll-FranseNeil K Aaronson
Jun 9, 2016·Journal of the National Medical Association·William N MkantaNabih R Asal
Apr 2, 2010·Statistical Methods in Medical Research·André L M Verbeek, Mireille J M Broeders
Apr 3, 2003·Nature Reviews. Cancer·Ruth EtzioniLeland Hartwell
Mar 17, 2006·Clinical Trials : Journal of the Society for Clinical Trials·Stuart G BakerSteven Skates
Dec 5, 2008·Scandinavian Journal of Urology and Nephrology. Supplementum·Tadao KakizoeMichael J Droller
Jul 14, 2019·Anatomical Sciences Education·Katerina BogomolovaSteven E R Hovius
Jul 4, 2020·Special Care in Dentistry : Official Publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry·Rafael Zancan MobileAntonio Adilson Soares de Lima
Sep 20, 2002·BMC Medical Research Methodology·Stuart G BakerPhilip C Prorok
Jun 3, 2017·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·Joana BastosManuel António Silva
Apr 12, 2003·BMC Medical Research Methodology·Stuart G BakerPhilip C Prorok
Dec 8, 2011·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Suzie J OttoUNKNOWN National Evaluation Team for Breast Cancer Screening

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.